By Cari Gallman, Executive Vice President, Corporate Affairs, Bristol Myers Squibb ·Updated December 19, 2023
I joined Bristol Myers Squibb almost nine years ago because I was personally moved by the company’s commitment to discover, develop and deliver innovative medicines for patients. BMS is in
